New insider activity at Tenet Healthcare ( (THC) ) has taken place on May 13, 2025.
Protect Your Portfolio Against Market Uncertainty
- Discover companies with rock-solid fundamentals in TipRanks' Smart Value Newsletter.
- Receive undervalued stocks, resilient to market uncertainty, delivered straight to your inbox.
Director Robert Kerrey recently sold 5,001 shares of Tenet Healthcare stock, amounting to a total transaction value of $742,653.
Recent Updates on THC stock
Tenet Healthcare has seen several price target increases from major financial firms following its strong Q1 performance. Truist raised its price target due to updated models reflecting Q1 results and guidance. RBC Capital increased its target, noting Tenet’s adjusted EBITDA exceeded expectations and highlighted the company’s potential to outperform its guidance due to significant operating leverage. UBS cited labor efficiencies and the potential of Tenet’s ambulatory surgery center strategy as reasons for its target increase. Guggenheim emphasized the ‘hefty’ EBITDA upside in Q1 as a positive start to 2025, while Barclays pointed to strong fundamentals and share repurchase plans as factors overshadowing policy and macro risks.
Spark’s Take on THC Stock
According to Spark, TipRanks’ AI Analyst, THC is a Outperform.
Tenet Healthcare demonstrates strong financial performance and technical momentum, with an attractive valuation. Key strengths include robust EBITDA growth and strategic capital management. However, the company must address revenue growth challenges and policy uncertainties to sustain this performance.
To see Spark’s full report on THC stock, click here.
More about Tenet Healthcare
YTD Price Performance: 18.85%
Average Trading Volume: 1,707,425
Technical Sentiment Signal: Strong Buy
Current Market Cap: $13.82B